Stockscreener 앱 받기
36.60
9.96%
-4.05
시간 외 거래:
36.60
Artivion Inc 주식(AORT)의 최신 뉴스
Artivion net income hits USD 2.4M in Q4 2025 - Medical Buyer
Why Artivion (AORT) Is Down 7.6% After Mixed Q4 Results And 2026 Guidance Above Consensus - Yahoo Finance
Artivion (NYSE:AORT) Cut to "Hold" at Wall Street Zen - MarketBeat
Artivion Earnings Call Highlights Growth, Margin Momentum - TipRanks
Artivion (AORT) Stock Trades Down, Here Is Why - Finviz
AORT Q4 Deep Dive: Stent Graft and On-X Growth Offset By Tissue Flatness, Guidance Highlights Pipeline - Finviz
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook - Investing.com Nigeria
Artivion (AORT) Analyst Rating Update: Price Target Lowered by C - GuruFocus
Artivion (NYSE:AORT) Given New $48.00 Price Target at Canaccord Genuity Group - MarketBeat
Artivion (NYSE:AORT) Stock Price Down 6.5%Time to Sell? - MarketBeat
Canaccord Genuity lowers Artivion stock price target to $48 on market compression - Investing.com
Canaccord Genuity lowers Artivion stock price target to $48 on market compression By Investing.com - Investing.com India
Artivion, Inc. (NYSE:AORT) Q4 2025 Earnings Call Transcript - Insider Monkey
Artivion Inc (AORT) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
Artivion Q4 Earnings Call Highlights - Yahoo Finance
Artivion Q4 2025 slides: double-digit growth across product lines, strong 2026 outlook By Investing.com - Investing.com South Africa
Artivion (AORT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Artivion earnings beat by $0.11, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Artivion Q4 2025 beats EPS forecast, stock rises - Investing.com
Artivion (NYSE:AORT) Misses Q4 CY2025 Sales Expectations - Finviz
Artivion (AORT) Q4 Earnings Surpass Estimates - Yahoo Finance
Artivion: Fourth Quarter Financial Highlights - Bitget
Artivion: Q4 Earnings Snapshot - Marietta Daily Journal
Artivion (NYSE:AORT) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Earnings Flash (AORT) Artivion, Inc. Reports Q4 Revenue $116.0M, vs. FactSet Est of $116.5M - marketscreener.com
Artivion shares fall as Q4 revenue misses analyst estimates By Investing.com - Investing.com Australia
Artivion shares fall as Q4 revenue misses analyst estimates - Investing.com
Artivion Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire
MACD Signal: Will Artivion Inc stock go up in YEARWatch List & Low Drawdown Momentum Ideas - baoquankhu1.vn
Artivion earnings on deck: Can revenue growth offset profit concerns? By Investing.com - Investing.com Nigeria
Artivion earnings on deck: Can revenue growth offset profit concerns? - Investing.com
Artivion Becomes Oversold (AORT) - Nasdaq
Aug Wrap: Is Artivion Inc stock undervalued right nowSwing Trade & Real-Time Buy Zone Alerts - baoquankhu1.vn
What To Expect From Artivion's (AORT) Q4 Earnings - Finviz
What To Expect From Artivion’s (AORT) Q4 Earnings - TradingView
Is PDF Solutions Inc subject to activist investor interest2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Market Recap: Is Artivion Inc stock undervalued right now2025 Technical Patterns & Technical Pattern Alert System - baoquankhu1.vn
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
US Market Recap: Whats the beta of Artivion Inc stockTake Profit & AI Driven Stock Price Forecasts - baoquankhu1.vn
Artivion (AORT) to Release Earnings on Thursday - MarketBeat
Earnings Miss: Is Artivion Inc a momentum stockJuly 2025 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
Aug Outlook: What is the long term forecast for Artivion Inc stock2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Sell Signal: Is Artivion Inc being accumulated by smart moneyJuly 2025 Momentum & Low Risk Growth Stock Ideas - baoquankhu1.vn
Artivion, Inc. (AORT) Investor Outlook: Potential Upside Of 25.43% And Strong Buy Ratings - DirectorsTalk Interviews
Artivion Reports Strong Q4 2025 Earnings and Positive Outlook for 2026 - Intellectia AI
Artivion reports positive clinical data from aortic arch trials By Investing.com - Investing.com Nigeria
The Analyst Verdict: Artivion In The Eyes Of 4 Experts - Benzinga
Needham Reiterates Buy Rating for Artivion (AORT) with $58 Targe - GuruFocus
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Artivion, Inc. Announces Presentation of Positive New Clinical Data from Endospan's Nexus Trial and its Amds PERSEVERE IDE Trial - marketscreener.com
Artivion (AORT) Unveils Promising Clinical Data from Key Trials - GuruFocus
Artivion reports positive clinical data from aortic arch trials - Investing.com
1.33%
0.51%
자본화:
|
볼륨(24시간):